fomesafen has been researched along with lysophosphatidylcholines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brophy, PJ; Cottrell, DF; Fleetwood-Walker, SM; Wallace, VC | 1 |
1 other study(ies) available for fomesafen and lysophosphatidylcholines
Article | Year |
---|---|
Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids.
Topics: Action Potentials; Animals; Behavior, Animal; Cannabinoids; Demyelinating Diseases; Disease Models, Animal; Drug Administration Routes; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Immunohistochemistry; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Mononeuropathies; Nerve Fibers, Myelinated; Neurons, Afferent; Neuropeptide Y; Pain; Peripheral Nerves; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Reflex; Sciatic Nerve; Sodium Channels | 2003 |